James L. Tyree, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 74,089 shares at $54.69 ($4.1M) on 2009-02-02, disclosed to the SEC on 2009-02-04.
Seasonal sale ($4.1M) by Executive Vice President — this insider has traded ABT in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.58 | 200 | $11K | 0.3% |
| 2 | $54.59 | 1,533 | $84K | 2.1% |
| 3 | $54.60 | 800 | $44K | 1.1% |
| 4 | $54.61 | 3,200 | $175K | 4.3% |
| 5 | $54.62 | 1,300 | $71K | 1.8% |
| 6 | $54.63 | 2,300 |
| $126K |
| 3.1% |
| 7 | $54.64 | 800 | $44K | 1.1% |
| 8 | $54.65 | 600 | $33K | 0.8% |
| 9 | $54.66 | 900 | $49K | 1.2% |
| 10 | $54.67 | 2,300 | $126K | 3.1% |
| 11 | $54.68 | 3,100 | $170K | 4.2% |
| 12 | $54.69 | 200 | $11K | 0.3% |
| 13 | $54.71 | 1,300 | $71K | 1.8% |
| 14 | $54.72 | 2,200 | $120K | 3.0% |
| 15 | $54.73 | 5,600 | $306K | 7.6% |
| 16 | $54.74 | 8,300 | $454K | 11.2% |
| 17 | $54.75 | 4,100 | $224K | 5.5% |
| 18 | $54.76 | 2,000 | $110K | 2.7% |
| 19 | $54.77 | 2,900 | $159K | 3.9% |
| 20 | $54.78 | 2,300 | $126K | 3.1% |
| 21 | $54.79 | 1,300 | $71K | 1.8% |
| 22 | $54.80 | 3,200 | $175K | 4.3% |
| 23 | $54.81 | 1,700 | $93K | 2.3% |
| 24 | $54.82 | 13,856 | $760K | 18.7% |
| 25 | $54.83 | 2,800 | $154K | 3.8% |
| 26 | $54.84 | 3,200 | $175K | 4.3% |
| 27 | $54.85 | 900 | $49K | 1.2% |
| 28 | $54.86 | 200 | $11K | 0.3% |
| 29 | $54.87 | 1,000 | $55K | 1.4% |
| Total | $54.75 avg | 74,089 | $4.1M | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |